349 related articles for article (PubMed ID: 27381367)
21. β2-Adrenergic receptor-dependent attenuation of hypoxic pulmonary vasoconstriction prevents progression of pulmonary arterial hypertension in intermittent hypoxic rats.
Nagai H; Kuwahira I; Schwenke DO; Tsuchimochi H; Nara A; Inagaki T; Ogura S; Fujii Y; Umetani K; Shimosawa T; Yoshida K; Pearson JT; Uemura K; Shirai M
PLoS One; 2014; 9(10):e110693. PubMed ID: 25350545
[TBL] [Abstract][Full Text] [Related]
22. Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox.
Nagaraj C; Tabeling C; Nagy BM; Jain PP; Marsh LM; Papp R; Pienn M; Witzenrath M; Ghanim B; Klepetko W; Weir EK; Heschl S; Kwapiszewska G; Olschewski A; Olschewski H
Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28729471
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide (NO)-dependent but not NO-independent guanylate cyclase activation attenuates hypoxic vasoconstriction in rabbit lungs.
Weissmann N; Voswinckel R; Tadic A; Hardebusch T; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F
Am J Respir Cell Mol Biol; 2000 Aug; 23(2):222-7. PubMed ID: 10919989
[TBL] [Abstract][Full Text] [Related]
24. Protein kinases in vascular smooth muscle tone--role in the pulmonary vasculature and hypoxic pulmonary vasoconstriction.
Ward JP; Knock GA; Snetkov VA; Aaronson PI
Pharmacol Ther; 2004 Dec; 104(3):207-31. PubMed ID: 15556675
[TBL] [Abstract][Full Text] [Related]
25. Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia.
Weissmann N; Manz D; Buchspies D; Keller S; Mehling T; Voswinckel R; Quanz K; Ghofrani HA; Schermuly RT; Fink L; Seeger W; Gassmann M; Grimminger F
Thromb Haemost; 2005 Sep; 94(3):630-8. PubMed ID: 16268482
[TBL] [Abstract][Full Text] [Related]
26. Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity.
Allen SW; Chatfield BA; Koppenhafer SA; Schaffer MS; Wolfe RR; Abman SH
Am Rev Respir Dis; 1993 Aug; 148(2):519-22. PubMed ID: 8342919
[TBL] [Abstract][Full Text] [Related]
27. Regulation, signalling and functions of hormonal peptides in pulmonary vascular remodelling during hypoxia.
Gaur P; Saini S; Vats P; Kumar B
Endocrine; 2018 Mar; 59(3):466-480. PubMed ID: 29383676
[TBL] [Abstract][Full Text] [Related]
28. Inhaled nitric oxide alters the distribution of blood flow in the healthy human lung, suggesting active hypoxic pulmonary vasoconstriction in normoxia.
Asadi AK; Sá RC; Kim NH; Theilmann RJ; Hopkins SR; Buxton RB; Prisk GK
J Appl Physiol (1985); 2015 Feb; 118(3):331-43. PubMed ID: 25429099
[TBL] [Abstract][Full Text] [Related]
29. Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling.
Pokreisz P; Fleming I; Kiss L; Barbosa-Sicard E; Fisslthaler B; Falck JR; Hammock BD; Kim IH; Szelid Z; Vermeersch P; Gillijns H; Pellens M; Grimminger F; van Zonneveld AJ; Collen D; Busse R; Janssens S
Hypertension; 2006 Apr; 47(4):762-70. PubMed ID: 16505204
[TBL] [Abstract][Full Text] [Related]
30. The emerging role of microRNAs in hypoxia-induced pulmonary hypertension.
Mohsenin V
Sleep Breath; 2016 Sep; 20(3):1059-67. PubMed ID: 27154628
[TBL] [Abstract][Full Text] [Related]
31. Effect of protein arginine methyltransferase-1 inhibition on hypoxia-induced vasoconstriction.
Kumarasamy C; Singh G; Raman P; Mala K
Med Hypotheses; 2015 Dec; 85(6):740-3. PubMed ID: 26527496
[TBL] [Abstract][Full Text] [Related]
32. Hypoxic pulmonary vasoconstriction.
Moudgil R; Michelakis ED; Archer SL
J Appl Physiol (1985); 2005 Jan; 98(1):390-403. PubMed ID: 15591309
[TBL] [Abstract][Full Text] [Related]
33. Notch Activation of Ca(2+) Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary Hypertension.
Smith KA; Voiriot G; Tang H; Fraidenburg DR; Song S; Yamamura H; Yamamura A; Guo Q; Wan J; Pohl NM; Tauseef M; Bodmer R; Ocorr K; Thistlethwaite PA; Haddad GG; Powell FL; Makino A; Mehta D; Yuan JX
Am J Respir Cell Mol Biol; 2015 Sep; 53(3):355-67. PubMed ID: 25569851
[TBL] [Abstract][Full Text] [Related]
34. Hypoxic pulmonary vasoconstriction: role of ion channels.
Mauban JR; Remillard CV; Yuan JX
J Appl Physiol (1985); 2005 Jan; 98(1):415-20. PubMed ID: 15591311
[TBL] [Abstract][Full Text] [Related]
35. High-altitude pulmonary edema.
Swenson ER; Bärtsch P
Compr Physiol; 2012 Oct; 2(4):2753-73. PubMed ID: 23720264
[TBL] [Abstract][Full Text] [Related]
36. Endothelin and pulmonary hypertension.
Chen YF; Oparil S
J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S49-53. PubMed ID: 10976782
[TBL] [Abstract][Full Text] [Related]
37. The endothelium in hypoxic pulmonary vasoconstriction.
Grimmer B; Kuebler WM
J Appl Physiol (1985); 2017 Dec; 123(6):1635-1646. PubMed ID: 28860164
[TBL] [Abstract][Full Text] [Related]
38. Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathways.
Rowan SC; Keane MP; Gaine S; McLoughlin P
Lancet Respir Med; 2016 Mar; 4(3):225-36. PubMed ID: 26895650
[TBL] [Abstract][Full Text] [Related]
39. Exercise training improves lung gas exchange and attenuates acute hypoxic pulmonary hypertension but does not prevent pulmonary hypertension of prolonged hypoxia.
Favret F; Henderson KK; Allen J; Richalet JP; Gonzalez NC
J Appl Physiol (1985); 2006 Jan; 100(1):20-5. PubMed ID: 16179398
[TBL] [Abstract][Full Text] [Related]
40. Hypoxic pulmonary vasoconstriction.
Sylvester JT; Shimoda LA; Aaronson PI; Ward JP
Physiol Rev; 2012 Jan; 92(1):367-520. PubMed ID: 22298659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
